Novel Therapies Targeting Cardioprotection and Regeneration.

Area of Science:

• Cardiology and Molecular Medicine
• Cardiovascular Research
• Regenerative Medicine

Background:

• Cardiovascular diseases (CVDs) are the primary cause of mortality worldwide.
• Cardiomyocytes are vital for heart function but susceptible to damage from various stressors, leading to cell death and fibrosis.
• Lost cardiomyocytes do not regenerate, resulting in impaired myocardial function.

Purpose of the Study:

• To review novel endogenous cardioprotective peptides and their therapeutic potential in cardiovascular diseases.
• To explore the role of exosomes and cardiac regeneration strategies in cardioprotection.
• To discuss challenges and future directions in harnessing cardioprotective therapies.

Main Methods:

• Literature review of current research on endogenous cardioprotective peptides.
• Analysis of therapeutic strategies including exosomes and cardiac regeneration.
• Discussion of the mechanisms of cardiomyocyte protection and potential clinical applications.

Main Results:

• Several endogenous peptides, including neuregulin-1, angiotensin-(1-9), GDF-11, GDF-15, and IGF-1, demonstrate cardioprotective effects.
• Exosomes and cardiac regeneration strategies show promise for treating heart damage.
• Challenges remain in optimizing these approaches for clinical use.

Conclusions:

• Novel endogenous peptides and advanced strategies like exosome therapy and cardiac regeneration offer significant potential for treating cardiovascular diseases.
• Further research is needed to overcome current challenges and fully realize the cardioprotective power of these approaches.
• These advancements may lead to more effective therapies for preventing cardiomyocyte death and preserving myocardial function.